Up-regulation of CB1 Cannabinoid Receptors Located at Glutamatergic Terminals in the Medial Prefrontal Cortex of the Obese Zucker Rat.
dc.contributor.author | Echeazarra, Leyre | |
dc.contributor.author | Barrondo Lacarra, Sergio | |
dc.contributor.author | García del Caño, Gontzal | |
dc.contributor.author | Bonilla del Río, Itziar | |
dc.contributor.author | Egaña Huguet, Jon | |
dc.contributor.author | Puente Bustinza, Nagore | |
dc.contributor.author | Aretxabala Rodríguez, Xabier | |
dc.contributor.author | Montaña, Mario | |
dc.contributor.author | López de Jesús, Maider | |
dc.contributor.author | González Burguera, Imanol | |
dc.contributor.author | Saumell Esnaola, Miquel | |
dc.contributor.author | Goicolea Altuna, María Aranzazu | |
dc.contributor.author | Grandes Moreno, Pedro Rolando | |
dc.contributor.author | Sallés Alvira, Joan | |
dc.date.accessioned | 2024-02-08T10:04:41Z | |
dc.date.available | 2024-02-08T10:04:41Z | |
dc.date.issued | 2022-10-18 | |
dc.identifier.citation | Frontiers in Neuroanatomy 16 : (2022) // Article ID 1004702 | es_ES |
dc.identifier.issn | 1662-5129 | |
dc.identifier.uri | http://hdl.handle.net/10810/65200 | |
dc.description.abstract | The present study describes a detailed neuroanatomical distribution map of the cannabinoid type 1 (CB1) receptor, along with the biochemical characterization of the expression and functional coupling to their cognate G i/o proteins in the medial prefrontal cortex (mPCx) of the obese Zucker rats. The CB1 receptor density was higher in the prelimbic (PL) and infralimbic (IL) subregions of the mPCx of obese Zucker rats relative to their lean littermates which was associated with a higher percentage of CB1 receptor immunopositive excitatory presynaptic terminals in PL and IL. Also, a higher expression of CB1 receptors and WIN55,212-2-stimulated [35S]GTPγS binding was observed in the mPCx but not in the neocortex (NCx) and hippocampus of obese rats. Low-frequency stimulation in layers II/III of the mPCx induced CB1 receptor-dependent long-term synaptic plasticity in IL of area obese Zucker but not lean rats. Overall, the elevated 2-AG levels, up-regulation of CB1 receptors, and increased agonist-stimulated [35S]GTPγS binding strongly suggest that hyperactivity of the endocannabinoid signaling takes place at the glutamatergic terminals of the mPCx in the obese Zucker rat. These findings could endorse the importance of the CB1 receptors located in the mPCx in the development of obesity in Zucker rats. | es_ES |
dc.description.sponsorship | This work was supported by grants of the Basque Government (grants numbers IT1230-19 and IT1620-22 to PG), the Spanish Government (grant numbers CTQ2017-85686-R to MG and JS) and the Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Frontiers Media | es_ES |
dc.relation | info:eu-repo/grantAgreement/MINECO/CTQ2017-85686-R | |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | 2-AG levels | es_ES |
dc.subject | CB1 receptor | |
dc.subject | Gi/o proteins | |
dc.subject | excitatory synapses | |
dc.subject | glutamatergic terminals | |
dc.subject | long-term potentiation | |
dc.subject | medial prefrontal cortex | |
dc.subject | obese Zucker rat | |
dc.title | Up-regulation of CB1 Cannabinoid Receptors Located at Glutamatergic Terminals in the Medial Prefrontal Cortex of the Obese Zucker Rat. | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | Copyright © 2022 Echeazarra, Barrondo, García del Caño, Bonilla-Del Río, Egaña-Huguet, Puente, Aretxabala, Montaña, López de Jesús, González-Burguera, Saumell-Esnaola, Goicolea, Grandes and Sallés. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) | * |
dc.relation.publisherversion | https://www.frontiersin.org/articles/10.3389/fnana.2022.1004702/full | |
dc.identifier.doi | 10.3389/fnana.2022.1004702 | |
dc.departamentoes | Farmacología | es_ES |
dc.departamentoes | Fisiología | es_ES |
dc.departamentoes | Neurociencias | es_ES |
dc.departamentoes | Química analítica | es_ES |
dc.departamentoeu | Farmakologia | es_ES |
dc.departamentoeu | Fisiologia | es_ES |
dc.departamentoeu | Kimika analitikoa | es_ES |
dc.departamentoeu | Neurozientziak | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Copyright © 2022 Echeazarra, Barrondo, García del Caño, Bonilla-Del Río, Egaña-Huguet, Puente, Aretxabala, Montaña, López de Jesús, González-Burguera, Saumell-Esnaola, Goicolea, Grandes and Sallés. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)